The U.S. FDA’s senior managers often lament the lack of routine increases in taxpayer funding, a concern that Michael Rogers, the associate FDA commissioner for regulatory affairs, reiterated during a May 1 webinar. Rogers said the agency’s field inspectorate will be working through a large number of retirements over the next few years, a predicament he said will continue to be “a huge challenge” to overcome.
EPA is announcing today that it’s issuing a waiver to allow the use of E15 nationwide again this summer, sources tell Agri-Pulse. The agency had previously issued such waivers for 2022 and 2023.
The U.S. FDA is undergoing a significant overhaul of operations which is designed in part to make the agency’s Office of Regulatory Affairs (ORA) more efficient and less obtrusive to product centers, such as the Center for Devices and Radiological Health.
Leaders of the House and Senate Ag committees have reached agreement on a one-year farm bill extension, but its fate hinges on whether Congress can agree on a stopgap spending bill this year.
A new coalition that includes consumer advocates and major industry groups plans to work with the FDA, as well as policymakers and media, to ensure the agency s new Human Foods Program has the vision and execution required to make needed cultural and organizational changes.